Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation

Molecular Cancer Research

Volumn 7, Issue 9, 2009, Pages 1582-1592

  Watanabe, Takuya ^a   Tsuda, Masumi ^a   Tanaka, Shinya ^a   Ohba, Yusuke ^a   Kawaguchi, Hideaki ^a   Majima, Tokifumi ^a   Sawa, Hirofumi ^b   Minami, Akio ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CRK LIKE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SMALL INTERFERING RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME RECONSTITUTION; GENE ACTIVITY; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SYNOVIAL SARCOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE; CELL GROWTH PROCESSES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; ENZYME ACTIVATION; HUMANS; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CRK; RAC GTP-BINDING PROTEINS; RNA INTERFERENCE; SARCOMA, SYNOVIAL; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; TYROSINE;

EID: 70349509457     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-09-0064     Document Type: Article

References (48)

1. Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structural similarity to phospholipase C. Nature 1988;332:272-275 (Pubitemid 18076660)
2. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992;12:3482-3489
3. Feller SM. Crk family adaptors - signalling complexformation and biological roles. Oncogene 2001;20:6348-6371
4. Hasegawa H, Kiyokawa E, Tanaka S, et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 1996;16:1770-1776 (Pubitemid 26095649)
5. Tanaka S, Morishita T, Hashimoto Y, et al. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci USA 1994;91:3443-3447 (Pubitemid 24130253)
6. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007;129:865-877 (Pubitemid 46802708)
7. Watanabe T, Tsuda M, Makino Y, et al. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol Cancer Res 2006;4:499-510. (Pubitemid 44197045)
8. Linghu H, Tsuda M, Makino Y, et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 2006;25: 3547-3556 (Pubitemid 43901676)
9. Wang L, Tabu K, Kimura T, et al. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4. Biochem Biophys Res Commun 2007;362:976-981 (Pubitemid 47390670)
10. Rodrigues SP, Fathers KE, Chan G, et al. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol Cancer Res 2005;3:183-194 (Pubitemid 40525329)
11. Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998;2:401-421
12. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents: the St. Jude Children's Research Hospital experience. J Clin Oncol 1994; 12:2660-2666 (Pubitemid 24217641)
13. Motoi T, Ishida T, Kuroda M, et al. Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma. Pathol Int 1998;48:769-775 (Pubitemid 28455694)
14. Watanabe T, Tsuda M, Makino Y, et al. Crk adaptor protein induced-phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration. Cell Res 2009;19:638-650
15. Kobashigawa Y, Sakai M, Naito M, et al. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat Struct Mol Biol 2007;14:503-510 (Pubitemid 46871805)
16. Wada Y, Shimada K, Kimura T, Ushiyama S. Novel p38 MAP kinase inhibitor R-130823 suppresses IL-6, IL-8 and MMP-13 production in spheroid culture of human synovial sarcoma cell line SW 982. Immunol Lett 2005;101:50-59
17. Lavoie JN, L'Allemain G, Brunet A, Müler R, Pouysséur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/ HOGMAPK pathway. J Biol Chem 1996;271:20608-20616 (Pubitemid 26281839)
18. 2/M transition and S phase progression in response to UV irradiation. Mol Cell 2005;17:37-48.
19. Bulavin DV, Phillips C, Nannenga B, et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 2004;36:343-350 (Pubitemid 38437256)
20. Nielsen TO, Hsu FD, O'Connell JX, et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 2003;163:1449-1456
21. Tamborini E, Bonadiman L, Greco A, et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin Cancer Res 2004;10:938-943 (Pubitemid 38198893)
22. Barbashina V, Benevenia J, Aviv H, et al. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathogenic study of 19 cases. J Cancer Res Clin Oncol 2002;128:610-616 (Pubitemid 35435558)
23. Thomas DG, Giordano TJ, Sanders D, et al. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma. Cancer 2005;103:830-838 (Pubitemid 40216413)
24. Terry J, Lubieniecka JM, Kwan W, Liu S, Nielsen TO. Hsp90 inhibitor 17- allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models. Clin Cancer Res 2005;11:5631-5638 (Pubitemid 41060842)
25. Tsuda M, Davis IJ, Argani P, et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 2007;67:919-929 (Pubitemid 46270745)
26. Feller SM, Knudsen B, Hanafusa H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 1994;13:2341-2351 (Pubitemid 24985606)
27. Gumienny TL, Brugnera E, Tosello-Trampont AC, et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001;107:27-41. (Pubitemid 32972035)
28. Mochizuki N, Ohba Y, Kobayashi S, et al. Crk activation of JNK via C3G and R-Ras. J Biol Chem 2000;275:12667-12671 (Pubitemid 30241416)
29. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
30. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995;81:1147-1157
31. Shin I, Kim S, Song H, Kim HR, Moon A. H-Ras-specific activation of Rac- MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem 2005;280:14675-14683 (Pubitemid 40562814)
32. Xu Q, Karouji Y, Kobayashi M, Ihara S, Konishi H, Fukui Y. The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma. Oncogene 2003;22:5537-5544 (Pubitemid 37102688)
33. Bulavin DV, Fornace AJ, Jr., p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 2004;92:95-118.
34. Nicke B, Bastien J, Khanna SJ, et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol Cell 2005;20:673-685 (Pubitemid 41740690)
35. Recio JA, Merlino G. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 2002;21:1000-1008 (Pubitemid 34174512)
36. Awasthi V, King RJ. PKC, p42/p44 MAPK, p38 MAPK are required for HGF-induced proliferation of H441 cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L942-9. (Pubitemid 30952014)
37. Tsuda M, Watanabe T, Seki T, et al. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1. Oncogene 2005; 24:7984-7990 (Pubitemid 41746742)
38. Chattopadhyay N, Tfelt-Hansen J, Brown EM. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Brain Res Mol Brain Res 2002;102:73-82. (Pubitemid 34607744)
39. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999;18:5311-5317 (Pubitemid 29462366)
40. Jin M, Piao Z, Kim NG, et al. p16 is a major inactivation target in hepatocellular carcinoma. Cancer 2000;89:60-68 (Pubitemid 30451274)
41. Broude EV, Swift ME, Vivo C, et al. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 2007;26:6954-6958
42. Passegué E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 2000;19:2969-2979 (Pubitemid 30386768)
43. Malumbres M, Péez De Castro I, Hernádez MI, Jiméez M, Corral T, Pellicer A. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Mol Cell Biol 2000;20:2915-2925 (Pubitemid 30183511)
44. 1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol 2004;287:C281-91.
45. Kawai A, Naito N, Yoshida A, et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett 2004;204:105-113 (Pubitemid 38117199)
46. Sonobe H, Manabe Y, Furihata M, et al. Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II. Lab Invest 1992;67:498-505.
47. Nojima T, Wang YS, Abe S, Matsuno T, Yamawaki S, Nagashima K. Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol Jpn 1990;40:486-493 (Pubitemid 20295351)
48. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-199